Breast cancer drug developer emerges after a dozen years with $54M round By: San Francisco Business Times via Business Journals July 22, 2020 at 17:52 PM EDT The company's Phase I/II study in metastatic breast cancer is its first clinical trial, and its looking for space to grow. Read More >>
